Medicine for treating pulmonary tuberculosis

A technology for pulmonary tuberculosis and medicine, applied in the field of medicine, can solve the problems of decreased curative effect, strong toxic and side effects of western medicine, prolonged course of treatment, etc., and achieve the effect of increasing IFN-γ content, good therapeutic effect, and improving thymus index.

Pending Publication Date: 2016-05-18
SHANDONG ZHONGHAI PHARMA CO LTD
View PDF2 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] At present, most of the drugs used to treat tuberculosis are western medicines. Although western medicines can kill Mycobacterium tuberculosis, due to the mutation of Mycobacterium tuberculosis, their drug resistance and drug resistance will increase, and the efficacy of western medicines will decrease significantly after being used for a period of time; Strong, damage the patient's health, reduce the patient's physique and immunity, lead to a decline in curative effect and prolong the course of treatment
Although the current traditional Chinese medicine for the treatment of pulmonary tuberculosis is toxic and has few side effects, it has the defects of slow effect, long course of treatment and low cure rate.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine for treating pulmonary tuberculosis
  • Medicine for treating pulmonary tuberculosis
  • Medicine for treating pulmonary tuberculosis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] Embodiment 1 A kind of medicine for the treatment of pulmonary tuberculosis

[0032] The drug is marine algae glycoprotein;

[0033] Said marine algae glycoprotein, in parts by weight, includes sugar 1%, protein 99%,

[0034] The molecular weight is 0.2kDa;

[0035] The marine algae are: cyanobacteria;

[0036] The sugar is a polysaccharide;

[0037] The polysaccharides include: xylose, fucose, arabinose, glucose, galactose, mannose, rhamnose;

[0038] The protein includes: asparagine, cysteine, lysine, arginine, serine, threonine;

Embodiment 2

[0039] Embodiment 2 A kind of medicine for the treatment of pulmonary tuberculosis

[0040] The drug is marine algae glycoprotein;

[0041] Said marine algae glycoprotein, in parts by weight, comprises sugar 6%, protein 85%,

[0042] The molecular weight is 25kDa;

[0043] The marine algae is: green algae;

[0044] The sugar is a polysaccharide;

[0045] The polysaccharides include: xylose, fucose, arabinose, glucose, galactose, mannose, rhamnose;

[0046] The protein includes: asparagine, cysteine, lysine, arginine, serine, threonine.

Embodiment 3

[0047] Embodiment 3 a kind of medicine for the treatment of pulmonary tuberculosis

[0048] The drug is marine algae glycoprotein;

[0049] Said marine algae glycoprotein, in parts by weight, comprises sugar 31%, protein 64%,

[0050] The molecular weight is 3kDa;

[0051] The marine algae are: cyanobacteria;

[0052] The sugar is a polysaccharide;

[0053] The polysaccharides include: xylose, fucose, arabinose, glucose, galactose, mannose, rhamnose;

[0054] The protein includes: asparagine, cysteine, lysine, arginine, serine, threonine.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
molecular weightaaaaaaaaaa
molecular weightaaaaaaaaaa
Login to view more

Abstract

The invention provides a medicine for treating pulmonary tuberculosis. The medicine is mixture of glucoprotein or polysaccharide and protein or is polypeptide or protein. The medicine provided by the invention has a favorable curative effect on pulmonary tuberculosis, is capable of obviously improving the sputum negative conversion rate, the focal absorption rate and the cavity closing rate, reducing the number of colonies of the lung and spleen, increasing the quantity of T lymphocytes CD4<+>T, increasing the thymus index and increasing the IFN-gamma content after being used for treating pulmonary tuberculosis for three months, is safe, efficient and free of side effect, and has obvious effects on preventing and treating pulmonary tuberculosis.

Description

technical field [0001] The invention relates to a medicine for treating pulmonary tuberculosis, which belongs to the technical field of medicine. Background technique [0002] Pulmonary tuberculosis is a chronic infectious disease. It does not necessarily occur after infection, and even if it occurs, symptoms will not appear immediately. It usually occurs after several months, years, or even decades, so it is difficult to detect in the early stage. Tuberculosis can occur throughout the year, and adolescents aged 15 to 35 are the peak age of tuberculosis, and may cause diabetes complicated by tuberculosis and pregnancy tuberculosis. [0003] Pulmonary tuberculosis is divided into 5 types: type I, primary pulmonary tuberculosis, primary pulmonary lesions, draining lymphangitis, hilar and / or mediastinal lymphatic tuberculous inflammation syndrome. Type II, hematogenous disseminated pulmonary tuberculosis, acute, subacute and chronic. Type III, infiltrative pulmonary tuberculo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/02A61K38/08A61P31/06A61P11/00A61K31/715A61K35/748A61K36/04A61K36/05A61K36/02A61K36/03A61K36/8945A61K35/64A61K31/7012
CPCA61K31/7012A61K31/715A61K35/748A61K36/02A61K36/03A61K36/04A61K36/05A61K36/195A61K36/315A61K36/428A61K36/704A61K36/8945A61K38/02A61K2300/00A61K38/08A61K38/168A61P31/06A61K31/351
Inventor 徐宝贞程潜程龙
Owner SHANDONG ZHONGHAI PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap